Sagimet Biosciences (NASDAQ:SGMT) Given New $46.00 Price Target at JMP Securities
Sagimet Biosciences (NASDAQ:SGMT – Free Report) had its price target trimmed by JMP Securities from $47.00 to $46.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a market outperform rating on the stock. Separately, The Goldman Sachs Group increased their price objective on Sagimet Biosciences from $30.00 to […]
More Stories
Mirador Capital Partners LP Purchases 1,319 Shares of KKR & Co. Inc. (NYSE:KKR)
Mirador Capital Partners LP grew its position in KKR & Co. Inc. (NYSE:KKR – Free Report) by 1.4% during the...
Hennion & Walsh Asset Management Inc. Sells 226 Shares of S&P Global Inc. (NYSE:SPGI)
Hennion & Walsh Asset Management Inc. cut its stake in shares of S&P Global Inc. (NYSE:SPGI – Free Report) by...
RMR Wealth Builders Purchases 189 Shares of S&P Global Inc. (NYSE:SPGI)
RMR Wealth Builders boosted its holdings in S&P Global Inc. (NYSE:SPGI – Free Report) by 6.6% during the 4th quarter,...
iShares Russell 2000 Value ETF (NYSEARCA:IWN) Sees Strong Trading Volume – Still a Buy?
iShares Russell 2000 Value ETF (NYSEARCA:IWN – Get Free Report) shares saw an uptick in trading volume on Thursday ....
PayPal (NASDAQ:PYPL) Given New $80.00 Price Target at Wells Fargo & Company
PayPal (NASDAQ:PYPL – Get Free Report) had its price objective hoisted by stock analysts at Wells Fargo & Company from...
BlackRock (NYSE:BLK) Given New $1,175.00 Price Target at Wells Fargo & Company
BlackRock (NYSE:BLK – Get Free Report) had its target price hoisted by equities researchers at Wells Fargo & Company from...